George Chelidonis
Overview
Explore the profile of George Chelidonis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nicolopoulou-Stamati P, Tsipis A, Chelidonis G, Patsouris E, Athanassiadou P, Gonidi M, et al.
Diagn Cytopathol
. 2014 Oct;
43(4):294-300.
PMID: 25355039
Background: Cytological differential diagnosis of atypical hyperplasia and well differentiated breast carcinoma may be challenging, because sometimes there is an overlap between the cytomorphological features of these lesions. The aim...
2.
Athanassiadou A, Lazaris A, Patsouris E, Tsipis A, Chelidonis G, Aroni K
Am J Dermatopathol
. 2012 Oct;
35(4):425-31.
PMID: 23095338
The development and progression of squamous cell carcinoma (SCC) of the skin is characterized by an accumulation of molecular changes. The aim of this study was to investigate the association...
3.
Gonidi M, Athanassiadou A, Patsouris E, Tsipis A, Dimopoulos S, Kyriakidou V, et al.
Pathol Res Pract
. 2011 May;
207(6):377-82.
PMID: 21621926
Mitochondria are the bioenergetic and metabolic centers of cells and play an important role in the regulation of cell death. The mitochondrial apoptosis pathway is controlled by the bcl-2 protein...
4.
Athanassiadou A, Tsipis A, Patsouris E, Gonidi M, Nicolopoulou-Stamati P, Chelidonis G, et al.
Acta Cytol
. 2011 Feb;
55(2):180-6.
PMID: 21325804
Background: The polycomb group protein enhancer of zeste homologue 2 (EZH 2) has been reported as a marker of aggressive breast cancer. The aim of this study was to investigate...
5.
Chelidonis G, Kavantzas N, Patsouris E, Pagaki E, Athanasiadou A, Agrogiannis G, et al.
Anal Quant Cytol Histol
. 2010 Aug;
31(5):332-9.
PMID: 20701101
Objective: To evaluate, in imprints of resected non-small cell lung cancers (NSCLCs), the relationship between DNA ploidy and E-cadherin/beta-catenin expression with classical prognostic factors. Study Design: A total of 45...
6.
Pagaki E, Patsouris E, Gonidi M, Athanassiadou A, Maurikakis M, Athanassiades P, et al.
Diagn Cytopathol
. 2010 May;
38(6):419-24.
PMID: 20474081
Metastasis is specific for malignant tumors and its control is one of the most important problems in the design of therapies for cancer patients. Loss or reduction of E-cadherin expression...